B
CRL icon

Baird’s Charles River Laboratories CRL Stock Holding History

Baird’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,983
Closed -$267K – 1110
2014
Q2 		$267K Sell
4,983
-6,188
-55% -$340K ﹤0.01% 1010
2014
Q1 		$674K Buy
11,171
+235
+2% +$13.7K 0.01% 763
2013
Q4 		$580K Buy
10,936
+11
+0.1% +$552 0.01% 786
2013
Q3 		$505K Sell
10,925
-199
-2% -$9.13K 0.01% 791
2013
Q2 		$456K Buy
+11,124
New +$477K 0.01% 797

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baird's CRL Position: Q3 2014 in Review

Baird sold out of Charles River Laboratories (CRL) in Q3 2014, closing a stake of 4,983 shares — an estimated $267K sold.

Baird first reported a position in CRL in Q2 2013 and held it in 5 quarters. The position peaked at $674K in Q1 2014. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

  • Baird reported no remaining Charles River Laboratories position as of Q3 2014 after selling out during the quarter.
  • Baird sold 4,983 Charles River Laboratories shares in Q3 2014, an estimated $267K.
  • Baird first reported a position in Charles River Laboratories in Q2 2013 and held it in 5 quarters.
  • Baird's Charles River Laboratories position peaked at $674K in Q1 2014.
  • 255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on Baird's 13F filing for Q3 2014, filed 12 Nov 2014.